Literature DB >> 600594

Intellectual assessment of 111 four-year-old children with phenylketonuria.

J C Dobson, M L Williamson, C Azen, R Koch.   

Abstract

Of the 216 children with phenylketonuria (PKU) who were initially enrolled in the Collaborative Study of Children Treated for Phenylketonuria, 203 were placed on dietary therapy between 3 and 92 days of age. Of these, 111 are now at least 4 years of age and constituted the sample for the present analysis. Their mean IQ on the Stanford Binet Intelligence Scale was 93 (1972 norms). The children assigned to two treatment groups based on "moderate" and "low" serum phenylalanine levels were comparable on their IQs at age 4, although many of the children could not be maintained in the specified categories. Females scored a significantly higher mean IQ than males (97 vs 90). Those children for whom dietary treatment was initiated during the first month of life scored a mean IQ of 95, compared with 85 for those initially treated from 31 to 65 days. However, the interpretation of dietary inception data may have been contaminated by familial and psychosocial factors. The PKU Collaborative Study is still in progress in 15 clinics located in 11 states.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 600594

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

Review 1.  Molecular genetics of phenylketonuria and its implications.

Authors:  H L Levy
Journal:  Am J Hum Genet       Date:  1989-11       Impact factor: 11.025

2.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

3.  Intellectual and school performances in early-treated classical PKU patients. The French collaborative study.

Authors:  J M Saudubray; F Rey; H Ogier; V Abadie; J P Farriaux; J Ghisolfi; P Guibaud; J Rey; M Vidailhet
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

4.  Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants.

Authors:  Lukana Ngiwsara; Nithiwat Vatanavicharn; Phannee Sawangareetrakul; Somporn Liammongkolkul; Pisanu Ratanarak; Boonchai Boonyawat; Chantragan Srisomsap; Voraratt Champattanachai; James Ketudat-Cairns; Pornswan Wasant; Jisnuson Svasti
Journal:  Mol Biol Rep       Date:  2021-03-07       Impact factor: 2.316

Review 5.  A research framework for evaluating the promotion of mental health and prevention of mental illness.

Authors:  L Eisenberg
Journal:  Public Health Rep       Date:  1981 Jan-Feb       Impact factor: 2.792

6.  A clinical epidemiologic study of hyperphenylalaninemia.

Authors:  R M Wrona
Journal:  Am J Public Health       Date:  1979-07       Impact factor: 9.308

7.  Intelligence and quality of dietary treatment in phenylketonuria.

Authors:  I Smith; M G Beasley; A E Ades
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 8.  Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria.

Authors: 
Journal:  BMJ       Date:  1993-01-09

Review 9.  Dietary interventions for phenylketonuria.

Authors:  Vanessa J Poustie; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

10.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.